Literature DB >> 24217252

Receptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility.

Benoit Boivin1, Fauzia Chaudhary, Bryan C Dickinson, Aftabul Haque, Stephanie C Pero, Christopher J Chang, Nicholas K Tonks.   

Abstract

We investigated the role of protein-tyrosine phosphatase α (PTPα) in regulating signaling by the ErbB2 oncoprotein in mammary epithelial cells. Using this model, we demonstrated that activation of ErbB2 led to the transient inactivation of PTPα, suggesting that attenuation of PTPα activity may contribute to enhanced ErbB2 signaling. Furthermore, RNAi-induced suppression of PTPα led to increased cell migration in an ErbB2-dependent manner. The ability of ErbB2 to increase cell motility in the absence of PTPα was characterized by prolonged interaction of GRB7 with ErbB2 and increased association of ErbB2 with a β1-integrin-rich complex, which depended on GRB7-SH2 domain interactions. Finally, suppression of PTPα resulted in increased phosphorylation of focal adhesion kinase on Tyr-407, which induced the recruitment of vinculin and the formation of a novel focal adhesion kinase complex in response to ErbB2 activation in mammary epithelial cells. Collectively, these results reveal a new role for PTPα in the regulation of motility of mammary epithelial cells in response to ErbB2 activation.

Entities:  

Keywords:  Breast Cancer; Cell Motility; Dephosphorylation; ErbB2; FAK; Oncogene; PTPα; Phosphatase; Phosphorylation; Protein Kinases

Mesh:

Substances:

Year:  2013        PMID: 24217252      PMCID: PMC3873551          DOI: 10.1074/jbc.M113.527564

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  The carboxyl-terminal tyrosine residue of protein-tyrosine phosphatase alpha mediates association with focal adhesion plaques.

Authors:  R Lammers; M M Lerch; A Ullrich
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

2.  Two mechanisms activate PTPalpha during mitosis.

Authors:  X M Zheng; D Shalloway
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

3.  Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies.

Authors:  K Nakamura; H Yano; E Schaefer; H Sabe
Journal:  Oncogene       Date:  2001-05-10       Impact factor: 9.867

Review 4.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

5.  Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.

Authors:  Stephanie C Pero; Lyn Oligino; Roger J Daly; Amy L Soden; Chen Liu; Peter P Roller; Peng Li; David N Krag
Journal:  J Biol Chem       Date:  2002-01-24       Impact factor: 5.157

6.  FAK integrates growth-factor and integrin signals to promote cell migration.

Authors:  D J Sieg; C R Hauck; D Ilic; C K Klingbeil; E Schaefer; C H Damsky; D D Schlaepfer
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

7.  Identification of p130cas as an in vivo substrate of receptor protein-tyrosine phosphatase alpha.

Authors:  A Buist; C Blanchetot; L G Tertoolen; J den Hertog
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

8.  Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo.

Authors:  E Ardini; R Agresti; E Tagliabue; M Greco; P Aiello; L T Yang; S Ménard; J Sap
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

9.  ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini.

Authors:  S K Muthuswamy; D Li; S Lelievre; M J Bissell; J S Brugge
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

10.  A phosphotyrosine displacement mechanism for activation of Src by PTPalpha.

Authors:  X M Zheng; R J Resnick; D Shalloway
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

View more
  11 in total

1.  PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK Signaling Pathway.

Authors:  Hong-Yun Zheng; Fu-Jin Shen; Yong-Qing Tong; Yan Li
Journal:  Curr Med Sci       Date:  2018-03-15

2.  A novel phosphatidic acid-protein-tyrosine phosphatase D2 axis is essential for ERBB2 signaling in mammary epithelial cells.

Authors:  Mathangi Ramesh; Navasona Krishnan; Senthil K Muthuswamy; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

Review 3.  The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.

Authors:  A Dittrich; H Gautrey; D Browell; A Tyson-Capper
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-12-28       Impact factor: 2.673

4.  Striatal-enriched protein tyrosine phosphatase regulates the PTPα/Fyn signaling pathway.

Authors:  Jian Xu; Pradeep Kurup; Ethan Foscue; Paul J Lombroso
Journal:  J Neurochem       Date:  2015-05-25       Impact factor: 5.372

5.  In Vitro Activity Assays to Quantitatively Assess the Endogenous Reversible Oxidation State of Protein Tyrosine Phosphatases in Cells.

Authors:  Avinash D Londhe; Syed H M Rizvi; Benoit Boivin
Journal:  Curr Protoc Chem Biol       Date:  2020-09

6.  The interaction of protein-tyrosine phosphatase α (PTPα) and RACK1 protein enables insulin-like growth factor 1 (IGF-1)-stimulated Abl-dependent and -independent tyrosine phosphorylation of PTPα.

Authors:  Ranvikram S Khanna; Hoa T Le; Jing Wang; Thomas C H Fung; Catherine J Pallen
Journal:  J Biol Chem       Date:  2015-02-18       Impact factor: 5.157

Review 7.  Receptor-type protein tyrosine phosphatases in cancer.

Authors:  Yu Du; Jennifer R Grandis
Journal:  Chin J Cancer       Date:  2014-10-17

8.  Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer.

Authors:  Zhidong Gu; Xuqian Fang; Chang Li; Changqiang Chen; Guangshu Liang; Xinming Zheng; Qishi Fan
Journal:  Int J Oncol       Date:  2017-06-23       Impact factor: 5.650

9.  Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models.

Authors:  Andrés Martín Toscani; Rocío G Sampayo; Federico Martín Barabas; Federico Fuentes; Marina Simian; Federico Coluccio Leskow
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

10.  PTPRA facilitates cancer growth and migration via the TNF-α-mediated PTPRA-NF-κB pathway in MCF-7 breast cancer cells.

Authors:  Canfeng Lin; Shubo Xin; Xiaoguang Huang; Feiran Zhang
Journal:  Oncol Lett       Date:  2020-08-20       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.